首页> 外国专利> 8-(octadecylosulphanyl)quinoline for use as a medicament, particularly for use in the treatment and prevention of the development of insulin resistance, a pharmaceutical composition containing 8-( octadecylosulphanyl)-quinoline and 8-( octadecylosulphanyl)quinoline applicable for the manufacture of a medicament for use in the treatment and prevention of the development of insulin resistance

8-(octadecylosulphanyl)quinoline for use as a medicament, particularly for use in the treatment and prevention of the development of insulin resistance, a pharmaceutical composition containing 8-( octadecylosulphanyl)-quinoline and 8-( octadecylosulphanyl)quinoline applicable for the manufacture of a medicament for use in the treatment and prevention of the development of insulin resistance

机译：用作药物，特别是用于治疗和预防胰岛素抵抗的药物的8-（十八烷基磺酰基）喹啉，包含8-（十八烷基磺酰基）-喹啉和8-（十八烷基磺酰基）喹啉的药物组合物，可用于制造一种用于治疗和预防胰岛素抵抗发展的药物

页面导航

摘要
著录项
相似文献

摘要

the subject of the invention is a 8 - (oktadecylosulfanylo) quinoline of formula 1 to use as medicine, especially for use in the treatment and prophylaxis of the development of insulin resistance.the invention also concerns pharmaceutical compositions, characterized by that it contains the active substance 8 - (oktadecylosulfanylo) quinoline and uses 8 - (oktadecylosulfanylo) quinoline to produce medicine for prevention of insulin resistance.

机译：本发明的主题是式1的8-（oktadecylosulfanylo）喹啉，其用作药物，特别是用于治疗和预防胰岛素抵抗的发展。本发明还涉及药物组合物，其特征在于其包含活性成分。物质8-（oktadecylosulfanylo）喹啉，并使用8-（oktadecylosulfanylo）喹啉来生产预防胰岛素抵抗的药物。

著录项

公开/公告号PL221449B1

专利类型
公开/公告日2016-04-29

原文格式PDF
申请/专利权人 INSTYTUT BIOLOGII DOŚWIADCZALNEJ IM. MARCELEGO NENCKIEGO PAN;UNIWERSYTET WARMIŃSKO-MAZURSKI W OLSZTYNIE;
展开▼

申请/专利号PL20120399880
发明设计人 KRZYSZTOF ZABŁOCKI;JANUSZ WASILEWSKI;
展开▼

申请日2012-07-09
分类号A61K31/47;A61P3/10;A61P3/04;A61P3;
国家 PL
入库时间 2022-08-21 14:23:42

相似文献

专利
外文文献
中文文献